UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 212

Sortiert nach

Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association

Circulation (New York, N.Y.), 2020-07, Vol.142 (4), p.e42-e63

2020

Volltextzugriff (PDF)

Combination Therapy in Hypertension

The journal of clinical hypertension (Greenwich, Conn.), 2011-03, Vol.13 (3), p.146-154

2011

Volltextzugriff (PDF)

Combination therapy in hypertension

Journal of the American Society of Hypertension, 2010-03, Vol.4 (2), p.90-98

2010

Volltextzugriff (PDF)

Combination therapy in hypertension

Journal of the American Society of Hypertension, 2010, Vol.4 (1), p.42-50

2010

Volltextzugriff (PDF)

Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

American journal of kidney diseases, 2008-09, Vol.52 (3), p.412-424

2008

Volltextzugriff (PDF)

One Size Does Not Fit All: The Role of Vasodilating β-Blockers in Controlling Hypertension as a Means of Reducing Cardiovascular and Stroke Risk

The American journal of medicine, 2010-07, Vol.123 (7), p.S9-S15

Basile, Jan N., MD

2010

Volltextzugriff (PDF)

The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM)

Journal of diabetes and its complications, 2013-05, Vol.27 (3), p.280-286

Basile, Jan N

2013

Volltextzugriff (PDF)

ASH 2015 Annual Primary Care Program: What you missed by not attending

Journal of the American Society of Hypertension, 2015-11, Vol.9 (11), p.831-836

Basile, Jan N., MD

2015

Volltextzugriff (PDF)

Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Hypertension (Dallas, Tex. 1979), 2006-09, Vol.48 (3), p.374-384

2006

Volltextzugriff (PDF)

Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance

Hypertension (Dallas, Tex. 1979), 2016-10, Vol.68 (4), p.888-895

2016

Volltextzugriff (PDF)

Rationale and Design for the Blood Pressure Intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

The American journal of cardiology, 2007-06, Vol.99 (12), p.S44-S55

2007

Volltextzugriff (PDF)

Ambulatory blood pressure monitoring to diagnose hypertension—an idea whose time has come

Journal of the American Society of Hypertension, 2016-02, Vol.10 (2), p.89-91

2016

Volltextzugriff (PDF)

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

The New England journal of medicine, 2010-04, Vol.362 (17), p.1575-1585

2010

Volltextzugriff (PDF)

376-P: REWIND Data on Obesity and Cardiovascular (CV) Health: Waist-to-Hip Ratio (WHR) Independently Predicted CV Outcomes

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Combination Angiotensin Receptor Blocker‐Neutral Endopeptidase Inhibitor Provides Additive Blood Pressure Reduction Over Angiotensin Receptor Blocker Alone

The journal of clinical hypertension (Greenwich, Conn.), 2010-10, Vol.12 (10), p.809-812

2010

Volltextzugriff (PDF)

Managing Hypertension in Older Adults

Current hypertension reports, 2024-04, Vol.26 (4), p.157-167

2024

Volltextzugriff (PDF)

Blood Pressure Control by Drug Group in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

The journal of clinical hypertension (Greenwich, Conn.), 2008-10, Vol.10 (10), p.751-760

2008

Volltextzugriff (PDF)

The Role of Nitric Oxide in Improving Endothelial Function and Cardiovascular Health: Focus on Nebivolol

The American journal of medicine, 2010-07, Vol.123 (7), p.S2-S8

2010

Volltextzugriff (PDF)

How We Got Where We Are in Blood Pressure Targets

Current hypertension reports, 2021-06, Vol.23 (6), p.33-33, Article 33

2021

Volltextzugriff (PDF)

Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs

Hypertension (Dallas, Tex. 1979), 2020-12, Vol.76 (6), p.1658-1663

2020

Volltextzugriff (PDF)

A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever

Hospital Practice, 2016-01, Vol.44 (1), p.9-20

Basile, Jan N.

2016

Volltextzugriff (PDF)

Plasma Renin Test–Guided Drug Treatment Algorithm for Correcting Patients With Treated but Uncontrolled Hypertension: A Randomized Controlled Trial

American journal of hypertension, 2009-07, Vol.22 (7), p.792-801

2009

Volltextzugriff (PDF)

Characteristics and Long-Term Follow-Up of Participants with Peripheral Arterial Disease During ALLHAT

Journal of general internal medicine : JGIM, 2014-11, Vol.29 (11), p.1475-1483

2014

Volltextzugriff (PDF)

From the President, American Society of Hypertension

Journal of the American Society of Hypertension, 2017-11, Vol.11 (11), p.697-697

2017

Volltextzugriff (PDF)

Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study

Journal of clinical lipidology, 2009-04, Vol.3 (2), p.109-118

2009

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(186)

Publikationsform

Sprache

Englisch
(211)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Life Sciences & Biomedicine
(91)
Humans
(89)
Cardiovascular System & Cardiology
(45)
Hypertension - Drug Therapy
(41)
Peripheral Vascular Disease
(40)
Antihypertensive Agents - Therapeutic Use
(34)
Female
(32)
Male
(31)
Risk Factors
(31)
Middle Aged
(27)
Aged
(26)
Hypertension
(26)
Departments
(25)
Biological And Medical Sciences
(23)
General & Internal Medicine
(23)
Medical Sciences
(23)
Blood Pressure - Drug Effects
(22)
Medicine, General & Internal
(22)
Cardiovascular Disease
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association

Combination Therapy in Hypertension

Combination therapy in hypertension

Combination therapy in hypertension

Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

One Size Does Not Fit All: The Role of Vasodilating β-Blockers in Controlling Hypertension as a Means of Reducing Cardiovascular and Stroke Risk

The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM)

ASH 2015 Annual Primary Care Program: What you missed by not attending

Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance

Rationale and Design for the Blood Pressure Intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

Ambulatory blood pressure monitoring to diagnose hypertension—an idea whose time has come

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

376-P: REWIND Data on Obesity and Cardiovascular (CV) Health: Waist-to-Hip Ratio (WHR) Independently Predicted CV Outcomes

Combination Angiotensin Receptor Blocker‐Neutral Endopeptidase Inhibitor Provides Additive Blood Pressure Reduction Over Angiotensin Receptor Blocker Alone

Managing Hypertension in Older Adults

Blood Pressure Control by Drug Group in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

The Role of Nitric Oxide in Improving Endothelial Function and Cardiovascular Health: Focus on Nebivolol

How We Got Where We Are in Blood Pressure Targets

Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs

A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever

Plasma Renin Test–Guided Drug Treatment Algorithm for Correcting Patients With Treated but Uncontrolled Hypertension: A Randomized Controlled Trial

Characteristics and Long-Term Follow-Up of Participants with Peripheral Arterial Disease During ALLHAT

From the President, American Society of Hypertension

Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study

Suchergebnisse filtern